Skip Nav Destination
Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia
Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms
Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients
Germline RBBP6 mutations in familial myeloproliferative neoplasms
Issue Archive
January 21 2016
In this Issue
Table of Contents
BLOOD FLASHBACK
INSIDE BLOOD COMMENTARIES
REVIEW ARTICLE
Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL
Clinical Trials & Observations
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial
CME
Clinical Trials & Observations
Yu Wei,Xue-bin Ji,Ya-wen Wang,Jing-xia Wang,En-qin Yang,Zheng-cheng Wang,Yu-qi Sang,Zuo-mu Bi,Cui-ai Ren,Fang Zhou,Guo-qiang Liu,Jun Peng,Ming Hou
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia
Clinical Trials & Observations
Philip A. Thompson,Constantine S. Tam,Susan M. O’Brien,William G. Wierda,Francesco Stingo,William Plunkett,Susan C. Smith,Hagop M. Kantarjian,Emil J. Freireich,Michael J. Keating
HEMATOPOIESIS AND STEM CELLS
Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice
Brief Report
Aparna Vasanthakumar,Stephen Arnovitz,Rafael Marquez,Janet Lepore,George Rafidi,Anase Asom,Madison Weatherly,Elizabeth M. Davis,Barbara Neistadt,Robert Duszynski,James W. Vardiman,Michelle M. Le Beau,Lucy A. Godley,Jane E. Churpek
IMMUNOBIOLOGY
MYELOID NEOPLASIA
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms
Clinical Trials & Observations
Jelena D. Milosevic Feenstra,Harini Nivarthi,Heinz Gisslinger,Emilie Leroy,Elisa Rumi,Ilyas Chachoua,Klaudia Bagienski,Blanka Kubesova,Daniela Pietra,Bettina Gisslinger,Chiara Milanesi,Roland Jäger,Doris Chen,Tiina Berg,Martin Schalling,Michael Schuster,Christoph Bock,Stefan N. Constantinescu,Mario Cazzola,Robert Kralovics
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
Xénia Cabagnols,Fabrizia Favale,Florence Pasquier,Kahia Messaoudi,Jean Philippe Defour,Jean Christophe Ianotto,Christophe Marzac,Jean Pierre Le Couédic,Nathalie Droin,Ilyas Chachoua,Remi Favier,M’boyba Khadija Diop,Valérie Ugo,Nicole Casadevall,Najet Debili,Hana Raslova,Christine Bellanné-Chantelot,Stefan N. Constantinescu,Olivier Bluteau,Isabelle Plo,William Vainchenker
RED CELLS, IRON, AND ERYTHROPOIESIS
TRANSPLANTATION
Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment
Johnnie J. Orozco,Aimee Kenoyer,Ethan R. Balkin,Ted A. Gooley,Donald K. Hamlin,D. Scott Wilbur,Mark D. Hylarides,Sofia H. L. Frost,Raya Mawad,Paul O’Donnell,Brenda M. Sandmaier,Ephraim J. Fuchs,Leo Luznik,Damian J. Green,Ajay K. Gopal,Oliver W. Press,John M. Pagel
LETTERS TO BLOOD
Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients
Clinical Trials & Observations
Marta Libura,Sebastian Giebel,Beata Piatkowska-Jakubas,Marta Pawelczyk,Izabella Florek,Karolina Matiakowska,Bozena Jazwiec,Katarzyna Borg,Iwona Solarska,Magdalena Zawada,Sylwia Czekalska,Jolanta Libura,Malgorzata Jakobczyk,Karolina Karabin,Monika Paluszewska,Malgorzata Calbecka,Justyna Gajkowska-Kulik,Grazyna Gadomska,Marek Kielbinski,Anna Ejduk,Dariusz Kata,Sebastian Grosicki,Agnieszka Wierzbowska,Slawomira Kyrcz-Krzemien,Krzysztof Warzocha,Kazimierz Kuliczkowski,Aleksander Skotnicki,Jerzy Holowiecki,Wieslaw Wiktor Jedrzejczak,Olga Haus
Germline RBBP6 mutations in familial myeloproliferative neoplasms
Clinical Trials & Observations
Ashot S. Harutyunyan,Roberto Giambruno,Christian Krendl,Alexey Stukalov,Thorsten Klampfl,Tiina Berg,Doris Chen,Jelena D. Milosevic Feenstra,Roland Jäger,Bettina Gisslinger,Heinz Gisslinger,Elisa Rumi,Francesco Passamonti,Daniela Pietra,André C. Müller,Katja Parapatics,Florian P. Breitwieser,Richard Herrmann,Jacques Colinge,Keiryn L. Bennett,Giulio Superti-Furga,Mario Cazzola,Emma Hammond,Robert Kralovics
BLOOD WORK
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS
-
Cover Image
Cover Image
MPLS204P UT7 cells were analyzed by confocal immunofluorescence using an anticalreticulin (endoplasmic reticulum marker) antibody in green and an antihemagglutinin (MPL detection) antibody in red. See the article by Cabagnols et al on page 333.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals